Literature DB >> 22568980

Emerging roles of the tumor-associated stroma in promoting tumor metastasis.

Yoshiya Horimoto1, Urszula M Polanska, Yuko Takahashi, Akira Orimo.   

Abstract

The stroma in human carcinomas consists of extracellular matrix and various types of non-carcinoma cells, mainly leukocytes, endothelial cells, fibroblasts, myofibroblasts and bone marrow-derived progenitors. The tumor-associated stroma actively supports tumor growth by stimulating neo-angiogenesis, as well as proliferation and invasion of apposed carcinoma cells. It has long been accepted that alterations within carcinoma cells mediate metastasis in a cell-autonomous fashion. Recent studies have, however, suggested an additional notion that cancer cells instigate local and systemic changes in the tumor microenvironment and contribute to niche formation for metastasis. Research, aiming to establish the roles of the tumor-associated stroma in facilitating the spread of carcinoma cells into distant organs, has provided an abundance of data and greater knowledge of the biology of metastatic carcinoma cells and associated stromal cells. This has stimulated further advances in the development of novel therapeutic approaches targeting tumor metastasis.

Entities:  

Mesh:

Year:  2012        PMID: 22568980      PMCID: PMC3427234          DOI: 10.4161/cam.20631

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  110 in total

1.  The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase.

Authors:  Sachie Hiratsuka; Akira Watanabe; Yoshiko Sakurai; Sachiko Akashi-Takamura; Sachie Ishibashi; Kensuke Miyake; Masabumi Shibuya; Shizuo Akira; Hiroyuki Aburatani; Yoshiro Maru
Journal:  Nat Cell Biol       Date:  2008-09-28       Impact factor: 28.824

Review 2.  Co-evolution of tumor cells and their microenvironment.

Authors:  Kornelia Polyak; Izhak Haviv; Ian G Campbell
Journal:  Trends Genet       Date:  2008-12-04       Impact factor: 11.639

3.  Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Authors:  Michael Gnant; Brigitte Mlineritsch; Walter Schippinger; Gero Luschin-Ebengreuth; Sabine Pöstlberger; Christian Menzel; Raimund Jakesz; Michael Seifert; Michael Hubalek; Vesna Bjelic-Radisic; Hellmut Samonigg; Christoph Tausch; Holger Eidtmann; Günther Steger; Werner Kwasny; Peter Dubsky; Michael Fridrik; Florian Fitzal; Michael Stierer; Ernst Rücklinger; Richard Greil; C Marth
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

Review 4.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

5.  Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.

Authors:  Sunhwa Kim; Hiroyuki Takahashi; Wan-Wan Lin; Pascal Descargues; Sergei Grivennikov; Youngjun Kim; Jun-Li Luo; Michael Karin
Journal:  Nature       Date:  2009-01-01       Impact factor: 49.962

6.  Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.

Authors:  Sabina Sangaletti; Emma Di Carlo; Silvia Gariboldi; Silvia Miotti; Barbara Cappetti; Mariella Parenza; Cristiano Rumio; Rolf A Brekken; Claudia Chiodoni; Mario P Colombo
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

7.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.

Authors:  Janine T Erler; Kevin L Bennewith; Thomas R Cox; Georgina Lang; Demelza Bird; Albert Koong; Quynh-Thu Le; Amato J Giaccia
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

Review 8.  Cancer-related inflammation.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica; Frances Balkwill
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

Review 9.  Stromal myofibroblasts are drivers of invasive cancer growth.

Authors:  Olivier De Wever; Pieter Demetter; Marc Mareel; Marc Bracke
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

10.  A paracrine requirement for hedgehog signalling in cancer.

Authors:  Robert L Yauch; Stephen E Gould; Suzie J Scales; Tracy Tang; Hua Tian; Christina P Ahn; Derek Marshall; Ling Fu; Thomas Januario; Dara Kallop; Michelle Nannini-Pepe; Karen Kotkow; James C Marsters; Lee L Rubin; Frederic J de Sauvage
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  21 in total

1.  Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.

Authors:  Jaime A Espinoza; Shakila Jabeen; Richa Batra; Elena Papaleo; Vilde Haakensen; Vera Timmermans Wielenga; Maj-Lis Møller Talman; Nils Brunner; Anne-Lise Børresen-Dale; Pavel Gromov; Åslaug Helland; Vessela N Kristensen; Irina Gromova
Journal:  Oncoimmunology       Date:  2016-10-24       Impact factor: 8.110

Review 2.  Rs-10889677 variant in interleukin-23 receptor may contribute to creating an inflammatory milieu more susceptible to bladder tumourigenesis: report and meta-analysis.

Authors:  Mohammed El-Gedamy; Zakaria El-Khayat; Hassan Abol-Enein; Afaf El-Said; Eslam El-Nahrery
Journal:  Immunogenetics       Date:  2021-03-04       Impact factor: 2.846

Review 3.  Why target the tumor stroma in melanoma?

Authors:  James Hutchenreuther; Andrew Leask
Journal:  J Cell Commun Signal       Date:  2017-11-06       Impact factor: 5.782

4.  Tumor microenvironment indoctrination: an emerging hallmark of cancer.

Authors:  Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

5.  Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion.

Authors:  Safinur Atay; Samagya Banskota; Jennifer Crow; Geetika Sethi; Lori Rink; Andrew K Godwin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

6.  S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.

Authors:  Claudia Maletzki; Peggy Bodammer; Anne Breitrück; Claus Kerkhoff
Journal:  Hepat Mon       Date:  2012-10-12       Impact factor: 0.660

7.  Endothelial hypoxic metabolism in carcinogenesis and dissemination: HIF-A isoforms are a NO metastatic phenomenon.

Authors:  Cristina Branco-Price; Colin E Evans; Randall S Johnson
Journal:  Oncotarget       Date:  2013-12

8.  Carcinoma-associated fibroblasts are a promising therapeutic target.

Authors:  Shinsaku Togo; Urszula M Polanska; Yoshiya Horimoto; Akira Orimo
Journal:  Cancers (Basel)       Date:  2013-01-31       Impact factor: 6.639

9.  Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro.

Authors:  Wenqing Cao; Jeffrey H Peters; Dylan Nieman; Meenal Sharma; Thomas Watson; JiangZhou Yu
Journal:  Br J Cancer       Date:  2015-08-11       Impact factor: 7.640

10.  The influence of cancer tissue sampling on the identification of cancer characteristics.

Authors:  Hui Xu; Xin Guo; Qiang Sun; Mengmeng Zhang; Lishuang Qi; Yang Li; Libin Chen; Yunyan Gu; Zheng Guo; Wenyuan Zhao
Journal:  Sci Rep       Date:  2015-10-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.